Analyst firms · Barclays · AMGN

Barclays AMGN price target and rating history

Amgen Inc. (AMGN) · Health Care

Barclays rates Amgen Inc. (AMGN) Equal Weight with a $185 price target, as of its latest action on Feb 20, 2026. It has published 5 rating actions on AMGN since November 2021, including 1 upgrade and 1 downgrade. Across 14 firms with a AMGN price target in the last 12 months, the median target is $371. Barclays's $185 is 50% below that.

Current rating
Equal Weight
Price target
$185
Median target, all firms
$371
Actions on AMGN
5

Barclays price target on AMGN

$300$243$18520222023202420252026
Barclays price target on AMGN, each point a stated target, November 2021 to February 2026.

Every Barclays rating on AMGN

How other firms rate AMGN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsMarket Perform$450Sep 8, 2026
Truist SecuritiesHold$362Aug 5, 2026
OppenheimerOutperform$450Aug 5, 2026
Morgan StanleyEqual-Weight$351Aug 5, 2026
RBC Capital MarketsOutperform$400Aug 5, 2026
BofA SecuritiesUnderperform$317Aug 5, 2026
Wells FargoEqual Weight$400Aug 5, 2026
Robert W. BairdUnderperform$230Aug 5, 2026
Canaccord GenuityHold$384Aug 5, 2026
Erste GroupHoldMay 5, 2026
JefferiesHold$350Mar 10, 2026
BarclaysEqual Weight$185Feb 20, 2026
BernsteinMkt Perform$335Jan 20, 2026
UBSBuy$380Jan 7, 2026
ScotiabankSector Outperform$385Nov 13, 2025

Questions about Barclays and AMGN

What is Barclays's price target for AMGN?
Barclays's latest stated price target for Amgen Inc. (AMGN) is $185, from its action on Feb 20, 2026.
What is Barclays's rating on AMGN?
Barclays rates AMGN Equal Weight, a neutral rating, as of Feb 20, 2026.
When did Barclays last change its view on AMGN?
On Feb 20, 2026, Barclays starts coverage at Equal Weight, price target $185.
How does Barclays's AMGN target compare with other analysts?
Across 14 firms with a AMGN price target in the last 12 months, the median target is $371. Barclays's $185 is 50% below that.

More AMGN rating histories

All Barclays ratingsAMGN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.